Skip to main content

Table 8 Compared baseline characteristics of the CardioBBEAT, TIM-HF and INH study participants

From: First outline and baseline data of a randomized, controlled multicenter trial to evaluate the health economic impact of home telemonitoring in chronic heart failure – CardioBBEAT

Variable CardioBBEAT TIM-HF INH
Usual care Monitoring Usual care Monitoring Usual care Monitoring
(n = 319) (n = 302) (n = 356) (n = 354) (n = 363) (n = 352)
Demographic profile       
  Age (years) 63.5 ± 11.4 62.5 ± 11.6 66.9 ± 10.5 66.9 ± 10.8 69.4 ± 11.5 67.7 ± 12.8
  Male sex (%) 88 87 82 81 71 71
  Living alone (%) 24 27 22 21 35 30
Clinical profile       
  NYHA class (%)       
   I 0 0 0 0 2 3
   II 65 73 51 50 62 54
   III 34 26 49 50 31 40
   IV 1 1 0 0 5 3
Risk factor profile       
  BMI (kg/m2) 28 ± 5 28 ± 5 28 ± 5 28 ± 5 n.a. n.a.
  Diabetes mellitus (%) 32 38 39 40 36 36
  Hypertension (%) 84 87 66 68 77 72
Diagnostic       
  Heart rate (1/min) 72 ± 14 72 ± 13 71 ± 13 71 ± 13 80 ± 18 80 ± 20
  LVEF (%) 31 ± 7 30 ± 8 27 ± 6 27 ± 6 30 ± 8 30 ± 8
Medication (%)       
  ACE inhibitor/ARB 93 93 97 94 87 89
  Beta blocker 95 96 93 92 79 81
  Diuretics 80 83 94 94 86 90
  1. ACE angiotensin converting enzyme, ARB angiotensin receptor blocker, BMI body mass index, LVEF left ventricular ejection fraction, n.a. not available, NYHA New York Heart Association, classification of heart failure